Pigmented fungiform papillae often go unnoticed, but any discoloration should be identified and documented by clinicians
Similarly, the amplified survival benefit observed among people with established comorbiditiessuch as cardiovascular or renal diseaseis likely attributable to their higher baseline risk
Why Patient Behavior Is Reshaping the GLP-1 Landscape In the fast-shifting world of obesity treatment, patient behavior is proving to be a powerful force, one that can make or break the success of even the most promising therapies
The pen versions of GLP-1s are delivered via subcutaneous injections meaning they are injected into the fatty tissue layer just below the skin, typically in the abdomen, thigh, or upper arm
M., Saranya, V., Vijayakumar, S., Mythili Meera, M., Ruprekha, S., Kunal, R., Pranay, A., Thomas, J., Mukherjee, A., & Chandrasekaran, N